SCHIRINZI, TOMMASO
 Distribuzione geografica
Continente #
NA - Nord America 13.677
AS - Asia 2.512
EU - Europa 1.631
SA - Sud America 468
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 18.334
Nazione #
US - Stati Uniti d'America 13.590
SG - Singapore 1.312
IT - Italia 561
BR - Brasile 390
CN - Cina 384
HK - Hong Kong 309
IE - Irlanda 207
KR - Corea 183
DE - Germania 169
UA - Ucraina 128
VN - Vietnam 116
RU - Federazione Russa 111
GB - Regno Unito 99
SE - Svezia 58
NL - Olanda 57
FR - Francia 52
CA - Canada 51
FI - Finlandia 51
IN - India 42
PL - Polonia 42
AR - Argentina 34
AT - Austria 32
BD - Bangladesh 30
MX - Messico 25
ID - Indonesia 23
JP - Giappone 22
ZA - Sudafrica 21
EC - Ecuador 16
TR - Turchia 15
JO - Giordania 14
ES - Italia 12
AL - Albania 9
IQ - Iraq 9
BE - Belgio 8
KG - Kirghizistan 8
CH - Svizzera 7
CO - Colombia 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
IR - Iran 5
LT - Lituania 5
MA - Marocco 5
PT - Portogallo 5
SA - Arabia Saudita 5
CZ - Repubblica Ceca 4
EU - Europa 4
PE - Perù 4
PY - Paraguay 4
VE - Venezuela 4
AU - Australia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
HN - Honduras 3
NP - Nepal 3
RS - Serbia 3
TH - Thailandia 3
TN - Tunisia 3
AZ - Azerbaigian 2
BO - Bolivia 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
KE - Kenya 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PK - Pakistan 2
PS - Palestinian Territory 2
RO - Romania 2
UY - Uruguay 2
BS - Bahamas 1
BY - Bielorussia 1
GA - Gabon 1
GR - Grecia 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
PA - Panama 1
SN - Senegal 1
SR - Suriname 1
SV - El Salvador 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 18.334
Città #
Wilmington 3.521
Houston 3.121
Woodbridge 2.641
Singapore 627
Fairfield 534
Ashburn 374
Chandler 363
Hong Kong 306
Ann Arbor 231
Seattle 225
Rome 195
Beijing 188
Cambridge 187
Dublin 180
Medford 129
New York 126
Santa Clara 121
Dallas 113
The Dalles 113
Dearborn 110
Jacksonville 91
Los Angeles 80
Lawrence 61
Buffalo 54
Council Bluffs 54
Milan 48
Menlo Park 45
Munich 37
São Paulo 36
Hanoi 34
Ho Chi Minh City 32
Nuremberg 27
Chicago 25
London 24
Redondo Beach 24
Brooklyn 22
Warsaw 22
Montreal 21
Moscow 21
San Diego 21
Tokyo 20
Toronto 20
Kraków 18
Zhengzhou 18
Johannesburg 17
Stockholm 17
Mexico City 16
Nanjing 16
Norwalk 15
Seoul 15
Boardman 14
Boston 14
Jakarta 14
Phoenix 14
Amman 13
Denver 13
Helsinki 13
Kunming 13
Lappeenranta 13
Orem 13
Chennai 12
Del Norte 12
Hefei 12
Monmouth Junction 12
Shanghai 12
Incheon 11
Poplar 11
Vienna 11
Creede 10
Durham 10
Guangzhou 10
Mountain View 10
Salt Lake City 10
Columbus 9
Manchester 9
Salvador 9
Verona 9
Amsterdam 8
Atlanta 8
Belo Horizonte 8
Florence 8
Redwood City 8
Rio de Janeiro 8
Bologna 7
Brussels 7
Center 7
Guarulhos 7
Saint Petersburg 7
Shenzhen 7
Turin 7
Ankara 6
Detroit 6
Engelhard 6
Frankfurt am Main 6
Genoa 6
Guayaquil 6
Palo Alto 6
Paris 6
San Jose 6
Tashkent 6
Totale 14.826
Nome #
Symptomatic nonconvulsive status epilepticus erroneously suggestive of sporadic Creutzfeldt-Jakob disease 604
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 489
Aberrant striatal synaptic plasticity in monogenic parkinsonisms 468
Regional specificity of synaptic plasticity deficits in a knock-in mouse model of DYT1 dystonia 468
Occurrence of Writing Tremor in Patients With Scans Without Evidence of Dopaminergic Deficit 435
A clinical and biochemical analysis in the differential diagnosis of idiopathic normal pressure hydrocephalus 432
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease. 424
Mild cerebello-thalamo-cortical impairment in patients with normal dopaminergic scans (SWEDD) 423
Impaired intracortical transmission in G2019S leucine rich-repeat kinase Parkinson patients 422
Exposure to low-dose rotenone precipitates synaptic plasticity alterations in PINK1 heterozygous knockout mice 416
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 416
Centrality of striatal cholinergic transmission in Basal Ganglia function 415
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson’s disease patients with chronic pain 413
Double hit mouse model of Parkinson's disease 413
PINK1 heterozygous mutations induce subtle alterations in dopamine-dependent synaptic plasticity 412
CSF biomarkers in superficial siderosis: a new tool for diagnosis and evaluation of therapeutic efficacy of deferiprone--a case report 412
Activation of 5-HT6 receptors inhibits corticostriatal glutamatergic transmission. 391
Negative allosteric modulation of mGlu5 receptor rescues striatal D2 dopamine receptor dysfunction in rodent models of DYT1 dystonia 384
Outlining a population "at risk" of Parkinson's disease: Evidence from a case-control study 384
Centrality of early synaptopathy in Parkinson's disease 359
Dietary Vitamin E as a Protective Factor for Parkinson's Disease: Clinical and Experimental Evidence 340
Transient parkinsonism after unilateral midbrain stroke: a compensatory intervention from the healthy side? 329
Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus 314
Promising rodent models in Parkinson's disease 310
Dopaminergic involvement in a drummer with focal dystonia: A case study 306
Continuous dopaminergic stimulation in a patient treated with daytime Levodopa-carbidopa intestinal gel and overnight Rotigotine: a case report 297
Assessment of serum uric acid as risk factor for tauopathies 281
Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease 277
Long-term treatment with rotigotine in drug-naïve PSP patients 257
Comments on: “Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review” 248
Altered profile and D2-dopamine receptor modulation of high voltage-activated calcium current in striatal medium spiny neurons from animal models of Parkinson's disease 247
The effect of postural deformities on back function and pain in patients with Parkinson's disease 246
CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients 245
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 245
Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy 242
Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction 223
Dystonia as a network disorder: A concept in evolution 215
Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: A systematic review and meta-analysis 212
Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features 197
Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease 192
Systemic activation of Nrf2 pathway in Parkinson's disease 177
Involvement of the Chemokine Prokineticin-2 (PROK2) in Alzheimer's Disease: From Animal Models to the Human Pathology 175
Cerebrospinal fluid ferritin and siderophages in the diagnosis of superficial cerebral siderosis 170
Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease 164
Technology-based assessment of motor impairment in de novo Parkinson's disease patients: implications for diagnostic accuracy and early identification of distinct phenotypes 150
Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease. 146
A Dual Centre Study of Pain in Parkinson's Disease and Its Relationship with Other Non-Motor Symptoms 146
The influence of postural deformities on neck function and pain in patients with Parkinson's disease 137
Transcranial Direct Current Stimolation (tDCS) on PD Patients with Freezing of Gait: Preliminary Findings 117
Assessment of Psychometric Characteristics of Parkinson’s Disease Sleep Scale 2 and Analysis of a Cut-Off Score for Detecting Insomnia in Italian Patients with Parkinson’s Disease: A Validation Study 117
Olfactory Neuron Prokineticin-2 as a Potential Target in Parkinson's Disease 115
Adult-onset sporadic chorea: real-world data from a single-centre retrospective study 110
Sex hormones differentially contribute to Parkinson disease in males: a multimodal biomarker study 103
Spinal vascular lesions: anatomy, imaging techniques and treatment 93
Ischemic injury precipitates neuronal vulnerability in Parkinson{'}s disease: Insights from PINK1 mouse model study and clinical retrospective data 88
The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia 87
Clinical course of paroxysmal dyskinesias throughout pregnancy 81
Physical activity changes and correlate effects in patients with Parkinson's disease during COVID-19 lockdown 80
Validation of the Italian version of the PSP Quality of Life questionnaire 77
Self-reported needs of patients with Parkinson's disease during COVID-19 emergency in Italy 76
COVID-19: dealing with a potential risk factor for chronic neurological disorders 74
Axial postural abnormalities and pain in Parkinson's disease 73
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 72
STN-DBS Induces Acute Changes in β-Band Cortical Functional Connectivity in Patients with Parkinson's Disease 72
Technology-based therapy-response and prognostic biomarkers in a prospective study of a de novo Parkinson’s disease cohort 72
Band-Specific Altered Cortical Connectivity in Early Parkinson's Disease and its Clinical Correlates 70
Insular and limbic abnormal functional connectivity in early-stage Parkinson’s disease patients with autonomic dysfunction 67
Contribution of testosterone and estradiol in sexual dimorphism of early-onset Parkinson's disease 67
Sex hormones shape EEG-based functional connectivity in early-stage Parkinson’s disease patients 66
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease 64
Parkinson's disease motor progression in relation to the timing of REM sleep behavior disorder presentation: an exploratory retrospective study 63
Substance P and Prokineticin-2 are overexpressed in olfactory neurons and play differential roles in persons with persistent post-COVID-19 olfactory dysfunction 63
Brain Functional Connectivity in de novo Parkinson's Disease Patients Based on Clinical EEG 63
Early Alterations in De Novo Parkinson’s Disease Revealed by Diffusion Tensor Imaging: Preliminary Study 61
Circulating calprotectin as a potential biomarker of persistent olfactory dysfunctions in Post-COVID-19 patients 61
Movement disorders in primary central nervous system lymphoma: two unreported cases and a review of literature 61
Tau and Amyloid-beta Peptides in Serum of Patients With Parkinson's Disease: Correlations With CSF Levels and Clinical Parameters 61
Motor cortex transcranial direct current stimulation improves non-motor symptoms in early-onset Parkinson’s disease: a pilot study 60
A biological characterization of patients with postmenopausal Parkinson's disease 58
Cortical functional connectivity changes in the body-first and brain-first subtypes of Parkinson's disease 58
Hearing dysfunction heralds an increase in non-motor burden and a worse quality of life in Parkinson’s disease: new insights from non-motor spectrum 56
Exploring the Association Linking Head Position and Sleep Architecture to Motor Impairment in Parkinson’s Disease: An Exploratory Study 56
Prevenzione del rischio di disturbo muscoloscheletrico in lavoratori videoterminalisti affetti da Malattia di Parkinson. Studio ergonomico e riabilitativo 56
Shaping the course of early-onset Parkinson’s disease: insights from a longitudinal cohort 55
Constipation distinguishes different clinical-biochemical patterns in de novo Parkinson's disease 54
Olfactory Neuron Substance P is Overexpressed in Parkinson's Disease Reflecting Gut Dysfunction 53
Pattern of Mitochondrial Respiration in Peripheral Blood Cells of Patients with Parkinson's Disease 53
Immunometabolic Signature and Tauopathy Markers in Blood Cells of Progressive Supranuclear Palsy 52
Post-COVID-19 Hyposmia Does Not Exhibit Main Neurodegeneration Markers in the Olfactory Pathway 51
Biofluids profile of ?-Klotho in patients with Parkinson{'}s disease 51
Increase of Prokineticin-2 in Serum of Patients with Parkinson{'}s Disease 50
Short‐Term Effects of Continuous Theta Burst Stimulation in Treating a Young Patient Affected by Post‐Ischemic Hemidystonia 50
Stage-dependent phosphoproteome remodeling of Parkinson's disease blood cells 49
Pregnancy, fertile life factors, and associated clinical course in PRKN early-onset Parkinson’s disease 49
Using a Video Device and a Deep Learning-Based Pose Estimator to Assess Gait Impairment in Neurodegenerative Related Disorders: A Pilot Study 47
Childhood Rapid-Onset Ataxia: Expanding the Phenotypic Spectrum of ATP1A3 Mutations 46
Oral Health and Use of Novel Transbuccal Drug Delivery Systems in Patients with Alzheimer’s and Parkinson’s Disease: A Review 46
Effects of head trauma and sport participation in young-onset Parkinson?s disease 45
Neutrophil-to-lymphocyte ratio and lymphocyte count reflect alterations in central neurodegeneration-associated proteins and clinical severity in Parkinson Disease patients 44
Clinical and neurochemical correlates of the APOE genotype in early-stage Parkinson's disease. 43
Totale 18.524
Categoria #
all - tutte 54.888
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.888


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.123 0 0 0 0 0 316 304 267 44 67 96 29
2021/2022793 31 61 60 40 6 63 143 41 38 64 72 174
2022/2023935 98 84 29 104 74 210 131 74 75 1 37 18
2023/2024532 41 14 24 12 51 113 31 71 16 52 24 83
2024/20252.790 58 505 224 146 86 279 193 227 239 292 312 229
2025/20262.089 392 191 595 426 454 31 0 0 0 0 0 0
Totale 18.795